New-onset diabetic ketoacidosis in a schizophrenic patient with multiple autoimmune disease during treatment with risperidone

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 32, Issue 2, 2008, Pages 577-578

  Sato, Yasushi ^a,b   Yasui Furukori, Norio ^a   Moriyama, Takako ^b   Kaneko, Sunao ^a  

^a HIROSAKI UNIVERSITY   (Japan)

^b Ohdate City Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTITHYROID AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; GLUCOSE; INSULIN; LEVOMEPROMAZINE; RISPERIDONE; TIAPRIDE;

ADDISON DISEASE; ADULT; AUTOIMMUNE DISEASE; AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 3; AUTOIMMUNE POLYENDOCRINOPATHY CANDIDIASIS ECTODERMAL DYSTROPHY; CASE REPORT; COMA; DIABETIC KETOACIDOSIS; DIABETIC NEPHROPATHY; FEMALE; GLUCOSE BLOOD LEVEL; GRAVES DISEASE; HUMAN; HYPERGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; LETTER; SCHIZOPHRENIA;

ANTIPSYCHOTIC AGENTS; AUTOIMMUNE DISEASES; COMORBIDITY; DIABETES MELLITUS, TYPE 1; DIABETIC KETOACIDOSIS; FEMALE; HUMANS; JAPAN; MIDDLE AGED; POLYENDOCRINOPATHIES, AUTOIMMUNE; RISPERIDONE; SCHIZOPHRENIA;

EID: 38749091761     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2007.08.039     Document Type: Letter

References (10)

1. Ananth J., Johnson K.M., Levander E.M., and Harry J.L. Diabetic ketoacidosis, neuroleptic malignant syndrome, and myocardial infarction in a patient taking risperidone and lithium carbonate. J Clin Psychiatry 65 (2004) 724
2. Betterle C., and Zanchetta R. Update on autoimmune polyendocrine syndromes (APS). Acta Biol Med 74 (2003) 9-33
3. Betterle C., Dal Pra C., Mantero F., and Zanchetta R. Autoimmune adrenal insufficiency and autoimmune polyendocrine syndromes: autoantibodies, autoantigens, and their applicability in diagnosis and disease prediction. Endocr Rev 23 (2002) 327-364
4. Dibben C.R., Kalavalapalli S.S., Linnington H.E., Hynes F.A., Dinneen S.F., Adler A.I., et al. Diabetes associated with atypical antipsychotic treatment may be severe but reversible: case report. Int J Psychiatry Med 35 (2005) 307-311
5. Fourlanos S., Dotta F., Greenbaum C.J., Palmer J.P., Rolandsson O., Colman P.G., et al. Latent autoimmune diabetes in adults (LADA) should be less latent. Diabetologia 48 (2005) 2206-2212
6. Lafayette J.M., Pirl W.F., and Henderson D.C. Low-dose clozapine and diabetic ketoacidosis. Psychosomatics 44 (2003) 249-252
7. Mithat B., Alpaslan T., Bulent C., and Cengiz T. Risperidone-associated transient diabetic ketoacidosis and diabetes mellitus type 1 in a patient treated with valproate and lithium. Pharmacopsychiatry 38 (2005) 105-106
8. Newcomer J.W. Metabolic considerations in the use of antipsychotic medications: a review of recent evidence. J Clin Psychiatry 68 Suppl 1 (2007) 20-27
9. Newcomer J.W., and Haupt D.W. The metabolic effects of antipsychotic medications. Can J Psychiatry 51 (2006) 480-491
10. Stern M.P. Type II diabetes mellitus. Interface between clinical and epidemiological investigation. Diabetes Care 11 (1988) 119-126